Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: A meta-analysis

Journal of Human Genetics

Volumn 50, Issue 2, 2005, Pages 84-91

  Zintzaras, Elias ^a   Stefanidis, Ioannis ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

Diabetes; Diabetic nephropathy; GLUT1; Meta analysis; Polymorphism

Indexed keywords

GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER; SLC2A1 PROTEIN, HUMAN;

ALLELE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; EQUILIBRIUM CONSTANT; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; GENETICS;

DIABETIC NEPHROPATHIES; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MONOSACCHARIDE TRANSPORT PROTEINS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 15944362595     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-004-0224-6     Document Type: Article

References (43)

1. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
2. S.A.G.E. Statistical analysis for genetic epidemiology. (2003) Computer program package available from Statistical Solutions Ltd, Cork, Ireland
3. Cardon LR, Palmer LJ (2003) Population stratification and spurious allelic association. Lancet 361:598-604
4. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101-129
5. de Jong DJ, van der Logt EM, van Schaik A, Roelofs HM, Peters WH, Naber TH (2003) Genetic polymorphisms in biotransformation enzymes in Crohn's disease: association with microsomal epoxide hydrolase. Gut 52:547-551
6. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
7. Grzeszczak W, Moczulski DK, Zychma M, Zukowska-Szczechowska E, Trautsolt W, Szydlowska I (2001) Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes. Kidney Int 59:631-636
8. Gutierrez C, Vendrell J, Pastor R, Broch M, Aguilar C, Llor C, Simon I, Richart C (1998) GLUT1 gene polymorphism in non-insulin-dependent diabetes mellitus: genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population. Diabetes Res Clin Pract 41:113-120
9. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, Cortes P (1995) Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96:1802-1814
10. Heilig CW, Liu Y, England RL, Freytag SO, Gilbert JD, Heilig KO, Zhu M, Concepcion LA, Brosius FC, III (1997) D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy. Diabetes 46:1030-1039
11. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560
12. Hodgkinson AD, Millward BA, Demaine AG (2001) Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy. Kidney Int 59:985-989
13. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC (1998) Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 47:821-830
14. Ioannidis JP (1998) Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA 279:281-286
15. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG (2003) Genetic associations in large versus small studies: an empirical assessment. Lancet 361:567-571
16. Iyengar SK, Fox KA, Schachere M, Manzoor F, Slaughter ME, Covic AM, Orloff SM, Hayden PS, Olson JM, Schelling JR, Sedor JR (2003) Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy. J Am Soc Nephrol 14:S195-S201
17. Krolewski AS, Warram JH, Rand LI, Kahn CR (1987) Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 317:1390-1398
18. Larkins RG, Dunlop ME (1992) The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35:499-504
19. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC (1992) Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327:248-254
20. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127:820-826
21. Lindner TH, Monks D, Wanner C, Berger M (2003) Genetic aspects of diabetic nephropathy. Kidney Int 63 (Suppl 84):S186-S191
22. Liu ZH, Guan TJ, Chen ZH, Li LS (1999) Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus. Kidney Int 55:1843-1848
23. Mahadevan P, Larkins RG, Fraser JR, Fosang AJ, Dunlop ME (1995) Increased hyaluronan production in the glomeruli from diabetic rats: a link between glucose-induced prostaglandin production and reduced sulphated proteoglycan. Diabetologia 38:298-305
24. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS (1998) Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 47:1164-1169
25. Mogyorosi A, Ziyadeh FN (1999) GLUT1 and TGF-beta: the link between hyperglycaemia and diabetic nephropathy. Nephrol Dial Transplant 14:2827-2829
26. Ng DP, Canani L, Araki S, Smiles A, Moczulski D, Warram JH, Krolewski AS (2002) Minor effect of GLUT1 polymorphisms on susceptibility to diabetic nephropathy in type 1 diabetes. Diabetes 51:2264-2269
27. Ntais C, Polycarpou A, Ioannidis JP (2003a) Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 12:120-126
28. Ntais C, Polycarpou A, Ioannidis JP (2003b) SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 12:618-624
29. Pritchard JK, Rosenberg NA (1999) Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 65:220-228
30. Quinn M, Angelico MC, Warram JH, Krolewski AS (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39:940-945
31. Satten GA, Flanders WD, Yang Q (2001) Accounting for unmeasured population substructure in case-control studies of genetic association using a novel latent-class model. Am J Hum Genet 68:466-477
32. Silverman EK, Palmer LJ (2000) Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol 22:645-648
33. Strojek K, Grzeszczak W, Morawin E, Adamski M, Lacka B, Rudzki H, Schmidt S, Keller C, Ritz E (1997) Nephropathy of type II diabetes: evidence for hereditary factors? Kidney Int 51:1602-1607
34. Tarnow L, Grarup N, Hansen T, Parving HH, Pedersen O (2001) Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients. Nephrol Dial Transplant 16:1653-1656
35. Valderrábano F, Berthoux FC, Jones EH, Mehls O (1996) Report on management of renal failure in Europe, XXV, 1994 end stage renal disease and dialysis report. The EDTA-ERA Registry. European Dialysis and Transplant Association- European Renal Association. Nephrol Dial Transplant 11(Suppl 1):S2-S21
36. Vardarli I, Baier LJ, Hanson RL, Akkoyun I, Fischer C, Rohmeiss P, Basci A, Bartram CR, Van Der Woude FJ, Janssen B (2002) Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 62:2176-2183
37. Weir BS (1996) Genetic data analysis II: Methods for discrete population genetic data. Sinauer Associates, Sunderland MA, USA
38. Weiss ST, Silverman EK, Palmer LJ (2001) Case-control association studies in pharmacogenetics. Pharmacogenomics J 1:157-158
39. Whitehead A (1997) A prospectively planned cumulative meta-analysis applied to a series of concurrent clinical trials. Stat Med 16:2901-2913
40. Whitehead A (2002) Meta-analysis of controlled clinical trials. Wiley, Chichester
41. Xu J, Turner A, Little J, Bleecker ER, Meyers DA (2002) Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? Hum Genet 111:573-574
42. Zintzaras E, Hadjigeorgiou GM (2004) Association of paraoxonase 1 (PON1) gene polymorphisms with risk of Parkinson's disease: a meta-analysis. J Hum Genet 49:474-481
43. Zintzaras E, Ioannidis JP (2004) Heterogeneity testing in meta-analysis of genome searches. Genet Epidem 28:123-137